earnings

NASDAQ · AKTX
Akari Therapeutics, Plc
Healthcare · Biotechnology
$8.23
Up+$0.13 (+1.54%)
Updated Oct 24, 2026, 4:56 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.22K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.13 – $29.32
- Volume
- 14.4K
- Avg. volume
- 1.09M
Price performance · AKTX
AKTX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
AKTX closed at $8.23 after 21 trading sessions, down 15.68% for the selected period.
- Last close
- $8.23
- Period change
- -15.68%
- Period low
- $7.28
- Period high
- $9.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $8.00 | $8.45 | $7.84 | $8.225 | 14.4K |
| Oct 22, 2026 | $8.69 | $9.115 | $7.58 | $8.10 | 20.89K |
| Oct 21, 2026 | $9.29 | $9.9387 | $8.70 | $8.76 | 30.6K |
| Oct 20, 2026 | $9.15 | $9.7249 | $9.15 | $9.29 | 35.12K |
| Oct 19, 2026 | $9.01 | $10.00 | $8.52 | $9.89 | 79.08K |
| Oct 16, 2026 | $8.72 | $8.72 | $8.025 | $8.18 | 21.69K |
| Oct 15, 2026 | $7.87 | $8.89 | $7.00 | $8.84 | 55.71K |
| Oct 14, 2026 | $8.0999 | $8.0999 | $7.19 | $7.28 | 34.94K |
| Oct 13, 2026 | $8.33 | $8.70 | $7.90 | $7.90 | 18.52K |
| Oct 12, 2026 | $8.70 | $9.05 | $8.34 | $8.54 | 112.4K |
| Oct 9, 2026 | $8.51 | $8.97 | $8.20 | $8.77 | 76.45K |
| Oct 8, 2026 | $8.61 | $8.73 | $8.13 | $8.13 | 61.88K |
| Oct 7, 2026 | $8.46 | $8.625 | $8.05 | $8.625 | 32.45K |
| Oct 6, 2026 | $8.96 | $8.96 | $8.13 | $8.39 | 19.78K |
| Oct 5, 2026 | $8.84 | $9.39 | $8.53 | $8.94 | 9.56K |
| Oct 2, 2026 | $9.01 | $9.14 | $8.26 | $8.72 | 15.26K |
| Oct 1, 2026 | $9.35 | $10.00 | $8.55 | $8.84 | 28.6K |
| Sep 30, 2026 | $9.58 | $10.05 | $8.80 | $9.30 | 46.96K |
| Sep 29, 2026 | $9.83 | $10.7474 | $9.55 | $9.72 | 50.67K |
| Sep 28, 2026 | $9.99 | $10.975 | $9.69 | $9.81 | 82.01K |
| Sep 25, 2026 | $10.25 | $10.25 | $9.30 | $9.755 | 71.54K |
Latest AKTX news
The latest Smart Investors Daily articles mentioning AKTX.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

